Patents by Inventor Christian Maasch

Christian Maasch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MCP-1 binding nucleic acids
    Publication number: 20130035376
    Abstract: The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group consisting of Type 1A nucleic acids, type 1B nucleic acids, Type 2 nucleic acids, Type 3 nucleic acids, Type 4 nucleic acids and nucleic acids comprising SEQ ID NOs:87-115
    Type: Application
    Filed: June 4, 2012
    Publication date: February 7, 2013
    Applicant: NOXXON PHARMA AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch
  • MCP-1 binding nucleic acids and use thereof
    Patent number: 8367629
    Abstract: The present invention is related to a nucleic acid molecule capable of binding to MCP-1, whereby the nucleic acid molecule is for use as a medicament for the treatment and/or prevention of a chronic disease or chronic disorder, preferably selected from the group consisting of chronic respiratory disease, chronic kidney disease and systemic lupus erythematosus.
    Type: Grant
    Filed: November 29, 2008
    Date of Patent: February 5, 2013
    Assignee: NOXXON Pharma AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch
  • SDF-1 binding nucleic acids
    Patent number: 8314223
    Abstract: The present invention is related to a nucleic acid molecule, preferably binding to SDF-1, selected from the group comprising type A nucleic acid molecules, type B nucleic acid molecules, type C nucleic acid molecules and nucleic acid molecules having a nucleic acid sequence according to any of SEQ ID NO:142, SEQ ID NO:143 or SEQ ID NO:144.
    Type: Grant
    Filed: January 18, 2009
    Date of Patent: November 20, 2012
    Assignee: NOXXON Pharma AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch, Nicole Dinse
  • MCP-1 binding nucleic acids
    Patent number: 8193159
    Abstract: The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group comprising type 1A nucleic acids, type 1B nucleic acids, type 2 nucleic acids, type 3 nucleic acids, type 4 nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ. ID. No. 87 to 115.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: June 5, 2012
    Assignee: NOXXON Pharma AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch
  • Ghrelin binding nucleic acids
    Publication number: 20120115937
    Abstract: The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3?-terminal stretch of nucleotides of the first stretch Box A hybridises with the second stretch Box B, whereby upon hybridisation a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.
    Type: Application
    Filed: January 24, 2012
    Publication date: May 10, 2012
    Applicant: NOXXON PHARMA AG
    Inventors: Florian Jarosch, Dirk Eulberg, Christian Maasch, Steffen Helmling, Sven Klussmann
  • Ghrelin binding nucleic acids
    Publication number: 20120083520
    Abstract: The present invention is related to a nucleic acid antagonist of ghrelin.
    Type: Application
    Filed: May 8, 2010
    Publication date: April 5, 2012
    Applicant: NOXXON PHARMA AG
    Inventors: Steffen Helmling, Dirk Eulberg, Christian Maasch, Sven Klussmann
  • C5A binding nucleic acids and the use thereof
    Publication number: 20120065254
    Abstract: The present invention is related to a nucleic acid molecule, capable of binding to C5a, whereby the nucleic acid molecule is for use in a method for the treatment and/or prevention of tumors, the treatment and/or prevention of a respiratory disease, the treatment and/or prevention of pain and/or the treatment and/or prevention of a neurodegenerative disorder.
    Type: Application
    Filed: March 23, 2010
    Publication date: March 15, 2012
    Applicant: NOXXON PHARMA AG
    Inventors: Florian Jarosch, Werner Purschke, Dirk Eulberg, Christian Maasch, Klaus Buchner, Sven Klussmann
  • Hepcidin Binding Nucleic Acids
    Publication number: 20120053234
    Abstract: The present invention is related to a nucleic acid capable of binding to hepcidin.
    Type: Application
    Filed: April 30, 2010
    Publication date: March 1, 2012
    Applicant: NOXXON PHARMA AG
    Inventors: Simone Sell, Frank Morich, Christian Maasch, Sven Klussmann, Nicole Dinse, Klaus Buchner, Frank Schwobel
  • Ghrelin binding nucleic acids
    Patent number: 8101734
    Abstract: The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3?-terminal stretch of nucleotides of the first stretch Box A hybridizes with the second stretch Box B, whereby upon hybridization a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: January 24, 2012
    Assignee: NOXXON Pharma AG
    Inventors: Florian Jarosch, Dirk Eulberg, Christian Maasch, Steffen Helmling, Sven Klussmann
  • SDF-1 Binding Nucleic Acids And The Use Thereof
    Publication number: 20110223127
    Abstract: The present invention is related to a nucleic acid molecule binding to SDF-1, whereby the nucleic acid molecule influences migration of cells.
    Type: Application
    Filed: August 6, 2008
    Publication date: September 15, 2011
    Applicant: NOXXON PHARMA AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch, Nicole Dinse
  • SDF-1 Binding Nucleic Acids
    Publication number: 20110112172
    Abstract: The present invention is related to a nucleic acid molecule, preferably binding to SDF-1, selected from the group comprising type A nucleic acid molecules, type B nucleic acid molecules, type C nucleic acid molecules and nucleic acid molecules having a nucleic acid sequence according to any of SEQ ID NO:142, SEQ ID NO:143 or SEQ ID NO:144.
    Type: Application
    Filed: January 18, 2009
    Publication date: May 12, 2011
    Applicant: NOXXON PHARMA AG
    Inventors: WERNER PURSCHKE, FLORIAN JAROSCH, DIRK EULBERG, SVEN KLUSSMANN, KLAUS BUCHNER, CHRISTIAN MAASCH, NICOLE DINSE
  • C5a binding nucleic acids
    Publication number: 20110046207
    Abstract: The present invention is related to a nucleic acid, preferably binding to C5a, selected from the group comprising type A nucleic acids, type B nucleic acids, type C nucleic acids, type D nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ.ID.No. 73 to 79.
    Type: Application
    Filed: September 24, 2008
    Publication date: February 24, 2011
    Applicant: NOXXON PHARMA AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch
  • CGRP binding nucleic acids
    Patent number: 7879991
    Abstract: The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
    Type: Grant
    Filed: May 6, 2003
    Date of Patent: February 1, 2011
    Assignee: NOXXON Pharma AG
    Inventors: Axel Vater, Christian Maasch, Florian Jarosch, Mathias Bell, Steffen Helmling, Bernd Eschgfäller, Elisabeth Moyroud, Sandra Stark, Sven Klussmann, Thorsten Ruppert, Gregor Bahrenberg, Clemens Gillen, Klaus Schiene
  • MCP-1 binding nucleic acids
    Publication number: 20100284961
    Abstract: The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group comprising type 1A nucleic acids, type 1B nucleic acids, type 2 nucleic acids, type 3 nucleic acids, type 4 nucleic acids and nucleic acids having a nucleic acid sequence according to any of SEQ. ID. No. 87 to 115.
    Type: Application
    Filed: February 14, 2007
    Publication date: November 11, 2010
    Applicant: NOXXON PHARMA AG
    Inventors: Werner Purschke, Florian Jarosch, Dirk Eulberg, Sven Klussmann, Klaus Buchner, Christian Maasch
  • Nucleic acids specifically binding bioactive ghrelin
    Publication number: 20100261291
    Abstract: The present invention is related to a nucleic acid specifically binding bioactive ghrelin, more preferably n-octanoyl ghrelin, and its use for the diagnosis of ghrelin mediated diseases and disorders.
    Type: Application
    Filed: February 24, 2010
    Publication date: October 14, 2010
    Applicant: NOXXON Pharma AG
    Inventors: SVEN KLUSSMANN, STEFFEN HELMLING, DIRK EULBERG, CHRISTIAN MAASCH, KLAUS BUCHNER
  • Ghrelin binding nucleic acids
    Patent number: 7750140
    Abstract: The present invention is related to an antagonist of ghrelin, wherein the antagonist is a nucleic acid, and whereby preferably the nucleic acid is binding to ghrelin.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: July 6, 2010
    Assignee: NOXXON Pharma AG
    Inventors: Steffen Helmling, Dirk Eulberg, Christian Maasch, Sven Klussmann
  • NOVEL USE OF SPIEGELMERS
    Publication number: 20090192100
    Abstract: The present invention relates to the use of a L-nucleic acid as intracellularly active agent.
    Type: Application
    Filed: May 4, 2006
    Publication date: July 30, 2009
    Inventors: Axel Vater, Christian Maasch, Sven Klussmann, Werner Purschke, Dirk Eulberg, Florian Jarosch, Klaus Buchner
  • MCP-1 Binding Nucleic Acids And Use Thereof
    Publication number: 20090156542
    Abstract: The present invention is related to a nucleic acid molecule capable of binding to MCP-1, whereby the nucleic acid molecule is for use as a medicament for the treatment and/or prevention of a chronic disease or chronic disorder, preferably selected from the group consisting of chronic respiratory disease, chronic kidney disease and systemic lupus erythematosus.
    Type: Application
    Filed: November 29, 2008
    Publication date: June 18, 2009
    Applicant: NOXXON PHARMA AG
    Inventors: WERNER PURSCHKE, FLORIAN JAROSCH, DIRK EULBERG, SVEN KLUSSMANN, KLAUS BUCHNER, CHRISTIAN MAASCH
  • Nucleic acids specifically binding bioactive ghrelin
    Publication number: 20070031840
    Abstract: The present invention is related to a nucleic acid specifically binding bioactive ghrelin, more preferably n-octanoyl ghrelin, and its use for the diagnosis of grelin mediated diseases and disorders.
    Type: Application
    Filed: November 10, 2004
    Publication date: February 8, 2007
    Applicant: NOXXON Pharma AG
    Inventors: Sven Klussmann, Steffen Helmling, Dirk Eulberg, Christian Maasch, Klaus Buchner
  • Ghrelin binding nucleic acids
    Publication number: 20060258607
    Abstract: The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises a first stretch Box A, and a second stretch Box B, whereby the first stretch Box A comprises about 25 consecutive nucleotides, the second stretch Box B comprises about six to eight consecutive nucleotides, whereby a 3?-terminal stretch of nucleotides of the first stretch Box A hybridises with the second stretch Box B, whereby upon hybridisation a first double-stranded structure is formed, whereby such first double-stranded structure comprises a bulge.
    Type: Application
    Filed: April 7, 2006
    Publication date: November 16, 2006
    Applicant: NOXXON Pharma AG
    Inventors: Florian Jarosch, Dirk Eulberg, Christian Maasch, Steffen Helmling, Sven Klussmann